Insider Buying Frenzy: Cangany’s Massive Purchases Spark Hope Amid Beneficient’s Turbulent Restructuring Flash.
Insider buying spree at Beneficient signals confidence amid restructuring turmoil—could lift stock to 2023 highs, but legal risks and earnings worries remain.
4 minutes to read

